WHO Officials Question Scientific Evaluation Of US FDA Vape

Dr. Reina Roa is an official from the World Health Organization (WHO). She does recently questioned the scientific evaluation of vapes and nicotine pouches by the US FDA in a statement. The statement is stating a lack of independent consensus and implying that its conclusions are influenced by the industry. This statement contradicts the consensus of major scientific institutions worldwide and is seen as a challenge to the credibility of the FDA and public health science.

We have organized important content:
1. Dr.Reina Roa, a Panamanian official who will soon serve as the President of 11th Conference of the Parties (COP11) at the World Health Organization, openly questioned the FDA’s scientific evaluation of harm reducing products such as vapes and nicotine pouches, stating a lack of independent consensus.
2. Several international authoritative institutions, including the Royal College of Physicians, Public Health England, and the National Academy of Sciences in the United States, have confirmed that non combustible nicotine products are significantly less harmful than cigarettes.
3. Roa’s remarks are seen as a challenge to the independence and scientific credibility of the FDA, and may also weaken the authority of WHO in public health governance.
4. Some analyses suggest that the WHO’s shift towards harm reduction in recent years may be related to funding cuts in the United States, rather than new scientific evidence.
5. If this stance continues at COP11, it may affect global tobacco control policies, particularly hindering low – and middle-income countries from adopting harm reduction strategies.
6. Academic and regulatory circles demand that WHO adhere to evidence-based recognition of the potential role of harm reduction products in reducing smoking related diseases and deaths.

Dr. Reina Roa stated in a statement that there is currently “no independent, industry unrelated scientific consensus” supporting that these products are significantly less harmful than cigarettes. Her remarks also imply that the FDA’s evaluation may lack independence. This statement is widely interpreted as a direct challenge to the credibility of US regulatory agencies and their scientific decision-making.

A large number of international and national authoritative institutions have reached a highly consistent conclusion on the risk status of harm reduction products. For example:
The Royal College of Physicians (2016): Long term inhalation of vapes is unlikely to cause harm exceeding 5% of smoking.
The UK Public Health Service (now known as the Office for Health Improvement and Differentiation): Vapes are at least 95% less harmful than smoking.
National Academy of Sciences, Engineering and Medicine (2018): Vapes release significantly fewer toxic substances than cigarettes.

However, industry analysts warn that such statements, if continued at COP11, could have significant implications for future global tobacco control policies. COP11, as the highest decision-making mechanism of FCTC, should have provided evidence-based guidelines for countries. However, if the chairman of the conference holds a position of denying existing scientific consensus, it may lead to policy discussions deviating from scientific basis, thereby delaying the implementation of harm reduction strategies in low – and middle-income countries.

Reference documents: WHO’s incoming tobacco chief launches smear against FDA | Blaze Media